Showing results (1-10 of 114) with videos related to
Sort By:
Pageof 12
BMC Health Services Research|October 27, 2007
Impact of prescription size on statin adherence and cholesterol levelsHolly A Batal, Mori J Krantz, Rita A Dale, et al.Journal of Addictive Diseases|December 2, 2008
Heterogeneous impact of methadone on the QTc interval: what are the practical implications?Mori J KrantzJournal of Psychiatric Practice|July 19, 2016
Caring for Patients With Severe and Enduring Eating Disorders (SEED): Certification, Harm Reduction, Palliative Care, and the Question of FutilityPatricia Westmoreland, Phillip S MehlerJournal of the American College of Cardiology|June 11, 2013
The ATLAS ACS 2-TIMI 51 trial and the burden of missing data: (Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects With Acute Coronary Syndrome ACS 2-Thrombolysis In Myocardial Infarction 51)Mori J Krantz, Sanjay KaulBMC Cardiovascular Disorders|July 20, 2004
Resting tachycardia, a warning sign in anorexia nervosa: case reportMori J Krantz, Philip S MehlerVascular Medicine (London, England)|May 4, 2006
Masterclass series in peripheral arterial disease. Antiplatelet therapy for peripheral arterial disease and claudicationWilliam R Hiatt, Mori J KrantzExpert Opinion on Pharmacotherapy|July 10, 2012
Synthetic opioids and arrhythmia risk: a new paradigm?Joseph L Schuller, Mori J KrantzArchives of Internal Medicine|February 11, 2004
Treating opioid dependence. Growing implications for primary careMori J Krantz, Philip S MehlerMedical Science Monitor : International Medical Journal of Experimental and Clinical Research|February 2, 2006
Paradoxical decrease in blood pressure after relief of cardiac tamponade: the role of sympathetic activityShane B Rowan, Mori J KrantzCardiology|January 31, 2012
Pericardial effusion in renal disease: to tap or not to tapMori J Krantz, James Brian ByrdPageof 12